FUJIFILM Pharmaceuticals U.S.A., Inc.

Providing next generation drug delivery technologies and CDMO services for precision treatment and care

""

Contract Development and Manufacturing Opportunities

One stop service provider for liposomes and lipid nanoparticles (LNP) tailored to project phase, from small scale formulation development to commercial scale manufacturing.

Diagram of a liposome.

Liposomes

Formulation design, process development, and scale-up supporting bench to commercial scale manufacturing of liposomes with high potency API handling.

Illustration of a liposome.

LNPs

Bench to commercial scale manufacturing of next-generation drug delivery technology fine-tuned for improved efficacy and safety.

""

mRNA

Process development and scale-up with bench to commercial scale mRNA manufacturing expertise.

 

701 Factory at Toyama site in Japan is an essential component to Fujifilm’s LNP GMP Manufacturing.

GMP Manufacturing

Upstream and downstream processing with aseptic fill & finish and batch release testing for a wide range of APIs with our purpose-built facility and expert staff.

Proprietary Ionizable Lipid Library

""

Lipid Licensing

pH-responsive lipids designed for in vivo/ex vivo nucleic acid delivery with enhanced bioavailability.

Drug Discovery and Development

""

Our Pipeline

Clinical trials assessing the potential of new drugs to address unmet medical needs in cancer and infectious diseases.

Applying Photo Film Expertise to Nano Drug Delivery

Fujifilm’s global center for new drug development, FUJIFILM Pharmaceuticals USA, Inc is one of Fujifilm’s synergistic Life Science businesses that offer products, services, and comprehensive solutions to support all stages of therapeutic development, from discovery through commercialization.